Enochian BioSciences, Inc. announced that Honorable Mark Dybul, M.D. has been named as Chief Executive Officer (CEO). Dr. Dybul, who has served as Executive Vice-Chair of the Board of Enochian BioSciences since January 2019, is a globally recognized leader in pandemics. He was a principal architect and ultimately the head of the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR), the large international health initiative in history dedicated to a single disease, that achieved historic prevention, care and treatment goals on time and on budget. During his tenure, the program grew from approximately $500 million to $6.5 billion annually.